2022 | Management of immune thrombocytopenia: 2022 update of Korean experts recommendations | 문영철; 박영훈 | Review |
2017 | Management of immune thrombocytopenia: Korean experts recommendation in 2017 | 문영철 | Review |
2015 | Manipulation of beta-catenin pathway to overcome endocrine resistance in breast cancer. | 이순남; 성주명; 이경은; 문영철; 남은미 | Meeting Abstract |
2011 | Matched-Pair Analysis Comparing Outcomes of Second Autologous Stem Cell Transplantation and Chemotherapy As a Salvage Therapy in Patients with Multiple Myeloma Who Relapsed After Front-Line Autologous Stem Cell Transplantation | 문영철 | Meeting Abstract |
2013 | Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT | 문영철 | Article |
2016 | MITOCHONDRIAL SPECIFIC ROS HYPEROXIDATION VIA PEROXIREDOXIN III HAS IMPORTANT ROLES ON ARSENIC TRIOXIDE INDUCED APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA | 이순남; 성주명; 유은선; 이경은; 문영철; 남은미; 우현애 | Meeting Abstract |
2011 | Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) | 문영철 | Article |
2018 | Multicenter retrospective analysis of clinical characteristics, treatment patterns, and outcomes in very elderly patients with diffuse large B-cell lymphoma: The Korean cancer study group LY16-01 | 문영철 | Article |
2015 | MUTATION ANALYSIS OF JAK2, MPL, CALR, ASXL1, TET2, IDH1, IDH2, DNMT3A, AND SF3B1 IN MYELOPROLIFERATIVE NEOPLASM | 문영철 | Meeting Abstract |
2010 | Myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura | 정화순; 성주명; 허정원; 문영철 | Article |
2011 | Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study | 문영철 | Meeting Abstract |
2015 | Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia | 문영철 | Article |
2017 | Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia | 허정원; 문영철; 정혜선; 정태동 | Article |
2023 | Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) | 문영철 | Article |
2022 | Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909) | 문영철 | Article |
2020 | Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia | 문영철 | Article |
2007 | Outgrowing endothelial cells that are derived from human umbilical cord blood improve neovascularization in hind-limb ischemia. | 성주명; 유은선; 권기환; 이경은; 문영철 | Meeting Abstract |
2020 | Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen species | 성주명; 유은선; 허정원; 이경은; 문영철; 남은미; 우현애 | Article |
2017 | PEROXIREDOXIN II ACTIVITY HAS IMPORTANT ROLES TO CONTROL ABL TYROSINE KINASE ACTIVITY IN STIS TREATED CML PATIENTS AND ITS POTENTIAL APPLICATION IN IMATINIB RESISTANCE | 문영철 | Meeting Abstract |
2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | 문영철 | Article |
2017 | Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia | 문영철 | Article |
2022 | Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma | 이경은; 문영철 | Article |
2011 | Polymorphisms of ERCC1 and ERCC5 genotypes were associated with response to imatinib therapy in chronic phase chronic myeloid leukemia | 공지현 | Doctoral Thesis |
2012 | Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia | 문영철 | Article |
2020 | Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study) | 문영철 | Article |
2005 | Potential usefulness of leukotriene B4 (LTB4) on mobilization of hematopoietic progenitor cells (HPC) | 성주명; 문영철 | Meeting Abstract |
2005 | Predictable prognostic factor of CD56 expression in acute myeloid leukemia with t(8 : 21) including allogeneic hematopoietic stem cell transplantation | 성주명; 문영철 | Meeting Abstract |
2007 | Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation | 성주명; 문영철 | Article |
2013 | Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib | 문영철 | Article |
2015 | PREDICTIVE FACTORS FOR TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH IMATINIB-TREATED, UNDETECTABLE MOLECULAR RESIDUAL DISEASE: RESULTS FROM THE KID STUDY | 문영철 | Meeting Abstract |